Markedly prolonged disease course, with breakthrough seizures, in a glioma with an isolated IDH1 mutation
Neurooncol Adv
.
2022 Jan 11;4(1):vdac004.
doi: 10.1093/noajnl/vdac004.
eCollection 2022 Jan-Dec.
Authors
Michael Drumm
1
,
Jessica W Templer
2
,
Matthew Tate
3
,
Lawrence Jennings
4
,
Craig Horbinski
3
4
Affiliations
1
Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
2
Department of Neurology, Northwestern University, Chicago, Illinois, USA.
3
Department of Neurological Surgery, Northwestern University, Chicago, Illinois, USA.
4
Department of Pathology, Northwestern University, Chicago, Illinois, USA.
PMID:
35128400
PMCID:
PMC8809516
DOI:
10.1093/noajnl/vdac004
No abstract available
Keywords:
IDH1 mutation; recurrence; seizure; survival.